VRL
VRL Diagnostics is a privately held specialty laboratory providing diagnostic, parasitology, microbiology, and clinical pathology testing services for laboratory animals, serving research institutions, pharmaceutical companies, and lab animal facilities across the U.S. and Asia.
- Company typePrivate
- Founded2004
- HeadquartersSan Antonio, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What VRL does
VRL Diagnostics is a privately held specialty laboratory services company founded in 2004 and headquartered in San Antonio, Texas, with operational presence in Maryland and an Asian footprint via VRL Asia/VRL China (vrlasia.cn). The company provides diagnostic testing, parasitology, microbiology, and clinical pathology services focused on laboratory animals used in biomedical research, supporting research institutions, pharmaceutical companies, and laboratory animal facilities. Its service portfolio is organized into two core offerings — Animal Health Monitoring (serology, PCR, bacteriology, parasitology, necropsy, histology, FELASA-compliant panels, and specialized NHP testing) and PreClinical BioAnalysis (clinical chemistry, hematology, coagulation, urinalysis, biomarkers, cell line pathogen screening, sterility, and STR-based cell line authentication) — supplemented by rapid services such as Cytoclear (24–48 hour turnaround) and the VRL TB IGRA Test, plus the Human B-virus exposure testing offered through partner ZE Labs.
Technically, VRL's platform centers on established molecular and immunological assay methodologies — PCR-based pathogen detection (including the recently launched BioBroom and BioDisk sample-preparation products with a "no-shake" workflow), ELISA platforms (including ready-to-use AAV TAb Kits for gene therapy research), and interferon-gamma release assays (TB IGRA) for non-human primate tuberculosis screening. The company emphasizes 30+ years of experience in NHP diagnostics and frames itself as one of the first commercial laboratories offering AAV antibody testing, signaling early-mover expertise in a fast-growing adjacent market.
Commercially, VRL operates a sales-led, enterprise-direct model. It runs an Azure-based client portal for report delivery, accepts quote requests via email ([email protected]), and serves both North American (USA) and Asian (China) markets. Revenue is generated on a professional-services basis from per-sample testing and customized animal health monitoring programs. The company is privately held with no disclosed institutional funding rounds, no public financials, and is led by founder-CEO Ron Berger; ownership structure is not publicly disclosed.
VRL firmographics
Firmographics- Name
- VRL
- Legal name
- VRL Diagnostics
- Website
- https://vrlsat.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- VRL Diagnostics is a privately held specialty laboratory providing diagnostic, parasitology, microbiology, and clinical pathology testing services for laboratory animals, serving research institutions, pharmaceutical companies, and lab animal facilities across the U.S. and Asia.
- Ownership category
- akta.pro rank
VRL industry classification
Industry- Product category
- Veterinary Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511), In-Vitro Diagnostic Substance Manufacturing (325413), Veterinary Services (541940), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Oncology Diagnostics (Liquid/Tissue Biomarkers, Flow Cytometry) (HLAMADAJ)
- akta.pro secondary industries
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI)
Keywords
Where VRL is headquartered
LocationHeadquarters
- HQ city
- San Antonio
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
VRL business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Laboratory Diagnostic Testing Services: VRL generates revenue through providing laboratory animal diagnostic testing services including serology, PCR, bacteriology, parasitology, necropsy profiles, histology, clinical pathology, and other specialized tests. Services are offered to research institutions, pharmaceutical companies, and laboratory animal facilities.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
VRL product offering
Product offeringCore offering
VRL Diagnostics is a CLIA-certified laboratory services company that provides diagnostic testing for laboratory animals and preclinical research specimens. Its portfolio includes serology and ELISA panels, PCR-based pathogen detection (including proprietary BioBroom and BioDisk products), bacteriology, parasitology, necropsy, histology, clinical chemistry, hematology, biomarkers, and cell line testing, sold primarily to research institutions, pharmaceutical companies, and laboratory animal facilities.
Product overview
VRL Diagnostics provides a comprehensive portfolio of laboratory animal diagnostic services organized into two core service areas: Animal Health Monitoring and PreClinical BioAnalysis. The Animal Health Monitoring suite includes serology panels (Serology Profiles, Individual Serology, Fast Track Profiles, FELASA Profiles), molecular testing (EnviroRAX PCR Profiles, Fecal PCR, Individual PCR), microbiology services (Bacteriology, Parasitology), pathology (Necropsy Profiles, Histology), and specialized offerings (Aquatics, Canine Serology, NHP testing, BioBroom and BioDisk PCR products, VRL Kits). The PreClinical BioAnalysis division provides clinical pathology testing (Clinical Chemistry, Hematology, Coagulation, Urine Analysis, Biomarkers) and cell line testing services (Cell Line Pathogen Screening, Sterility, Cell Line Authentication). Additional offerings include AAV Neutralizing Antibody Testing for gene therapy research, VRL TB IGRA Test for NHP tuberculosis screening, and Cytoclear for rapid 24-48 hour results. ZE Labs provides Human B-virus exposure testing from a CLIA-certified laboratory.
Differentiator
Problem solved
Functional benefit
Brands
- BioBroom: PCR-based pathogen detection product for efficient and clean testing
- BioDisk
- Cytoclear
- ZE Labs
- VRL TB IGRA Test
- AAV TAb Kits
Products and services
- Animal Health Monitoring Comprehensive diagnostic testing services for laboratory animal colonies including serology, PCR, bacteriology, parasitology, and necropsy profiles to ensure colony health and data integrity for research institutions, pharmaceutical companies, and vivaria.
- PreClinical BioAnalysis Laboratory testing services supporting preclinical research including clinical chemistry, hematology, coagulation, histology, biomarkers, and cell line screening for pharmaceutical and biotech sponsors.
- AAV Neutralizing Antibody Testing
- BioBroom and BioDisk
- AAV TAb Kits
- VRL TB IGRA Test
- Cytoclear Rapid Testing
- ZE Labs Human B-virus Exposure Testing
- Cell Line Authentication (STR)
- Sterility Testing
- Cell Line Pathogen Screening
- Histology
- FELASA Profiles
- NHP (Non-Human Primate) Diagnostic Testing
- Serology Profiles
Companies that use VRL
Customer profileSegments2 records
Ideal customer profiles2 records
VRL technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
VRL partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor.
- ZE LabsminorZE Labs offers Human B-virus Exposure Testing from a CLIA certified laboratory. VRL highlights this partnership on their homepage, indicating a collaborative relationship for providing critical life-saving answers when time and detection is critical.
- BRAD (Biomedical Research Awareness Day)minorVRL is a proud BRAD sponsor, supporting biomedical research awareness initiatives. This sponsorship demonstrates VRL's commitment to the broader research community and awareness programs.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
VRL competitors and assessment
Company assessmentBroad incumbents
- Eurofins Scientific: Eurofins runs one of the world's largest testing laboratory networks, including preclinical, genomic, and pharmaceutical testing services. Comparable on the molecular diagnostics (PCR/qPCR) and bioanalytical testing side and a credible alternative for global biopharma sponsors.
- Labcorp Drug Development (formerly Covance): Labcorp's drug development arm offers central lab, preclinical, and bioanalytical services for global biopharma. Comparable on PreClinical BioAnalysis (clinical chemistry, hematology, biomarkers) but at materially greater scale and geographic reach.
- Zoetis Reference Laboratories: Zoetis operates a reference lab network serving veterinary clinics; while primarily companion-animal focused, the diagnostics platform and global lab infrastructure are comparable on veterinary/animal diagnostic testing methodology and scale.
- WuXi AppTec (WuXi Biology / WuXi Testing): WuXi AppTec is a global CRO/CDMO with preclinical biology and bioanalytical testing capabilities. Directly comparable on PreClinical BioAnalysis and adjacent on AAV-related biologics testing, though primarily serving a different (China-heavy) geographic mix.
Emerging players
- North American Science Associates (NAMSA): NAMSA is a medical device and biologics-focused CRO offering preclinical testing, biocompatibility, and microbiology services. Comparable on PreClinical BioAnalysis and biological testing (sterility, cell line authentication) for regulated research clients.
- Bionova Scientific: Bionova Scientific provides GMP biologics testing, cell bank characterization, sterility, and viral clearance services for cell and gene therapy clients. Comparable on the cell line pathogen screening, sterility, and AAV-related testing offerings, with overlap on gene therapy clients.
Direct peers
- Inotiv: Inotiv (formed via the Envigo–BASI merger) provides research models, contract research, and preclinical safety/pathology services, including animal health diagnostics. Comparable on PreClinical BioAnalysis and overlapping serology/PCR capabilities.
- Charles River Laboratories: Charles River operates the largest preclinical/research animal diagnostics portfolio (CRL Research Animal Diagnostic Services) covering serology, PCR, and pathology for rodent and NHP colonies, plus full preclinical CRO services. Directly comparable on the Animal Health Monitoring side and adjacent on PreClinical BioAnalysis.
- Marshall BioResources: Marshall BioResources supplies purpose-bred NHPs and operates NHP-specific health monitoring and diagnostic services. Closely comparable on the NHP testing franchise, including TB screening and colony health monitoring.
- IDEXX BioAnalytics: IDEXX BioAnalytics is the leading specialty lab for research animal health monitoring, offering serology, PCR, and parasitology panels for academic and biopharma vivaria. Closest direct competitor on colony health testing for mice, rats, and NHPs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
VRL social profiles
Digital presenceVRL financial estimates
Financial estimateRevenue estimate
Valuation estimate
VRL leadership team
Management profileNumber of profiles
Profiles1 record
VRL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VRL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VRL
What does VRL do?
VRL Diagnostics is a CLIA-certified laboratory services company that provides diagnostic testing for laboratory animals and preclinical research specimens. Its portfolio includes serology and ELISA panels, PCR-based pathogen detection (including proprietary BioBroom and BioDisk products), bacteriology, parasitology, necropsy, histology, clinical chemistry, hematology, biomarkers, and cell line testing, sold primarily to research institutions, pharmaceutical companies, and laboratory animal facilities.
Is VRL a public or private company?
VRL is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was VRL founded?
VRL was founded in 2004. It employs 51 to 100 people.
Where is VRL based?
VRL is headquartered in San Antonio, United States, in the North America region.
How does VRL make money?
One revenue line is on record: laboratory Diagnostic Testing Services.
Who are VRL's main competitors?
Broad incumbents on record are Eurofins Scientific, Labcorp Drug Development (formerly Covance), Zoetis Reference Laboratories and WuXi AppTec (WuXi Biology / WuXi Testing). Emerging players are North American Science Associates (NAMSA) and Bionova Scientific. Direct peers are Inotiv, Charles River Laboratories, Marshall BioResources and IDEXX BioAnalytics.
Does VRL have an API?
No public API is recorded for VRL.
What industry is VRL in?
VRL's product category is Veterinary Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAMADAJ, Oncology Diagnostics (Liquid/Tissue Biomarkers, Flow Cytometry), with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 621511 and its SIC code is 8071.